Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-d]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Family.
J Med Chem
; 59(17): 8103-24, 2016 09 08.
Article
en En
| MEDLINE
| ID: mdl-27491023
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Piridinas
/
Pirimidinas
/
Quinazolinas
/
Morfolinas
/
Quinazolinonas
/
Receptores ErbB
/
Antineoplásicos
Tipo de estudio:
Prognostic_studies
Idioma:
En
Año:
2016
Tipo del documento:
Article